TrialPanorama/Dataset huggingface dataset:
Please select the eligibility criteria that correspond to the clinical trial below.
Title: Testing the Leadership and Organizational Change for Implementation (LOCI) Intervention in Substance Abuse Treatment Programs
Brief Summary: This study will test the effects of the Leadership and Organizational Change for Implementation (LOCI) intervention in facilitating evidence-based practice (EBP) implementation in substance use disorder (SUD) and HIV services settings. LOCI improves implementation leadership and organizational support to develop strategic climate for EBP implementation. Greater efficiency and effectiveness of EBP implementation will improve the public health impact of evidence-based health and allied healthcare innovations and lead to greater effectiveness of SUD and HIV services.

Project Terms:


Options:
A: Inclusion Criteria:

* Substance use disorder treatment service providers, supervisors, agency executives/managers
* Supervisors will be the only individuals eligible to participate in the experimental (LOCI) or control condition (internet based) leadership intervention.
* Only supervisors in the experimental (LOCI) condition will be eligible to participate in focus groups.
* Only agency executives/managers participating in the organizational strategy development meetings of the LOCI intervention condition will be eligible to participate in interviews.

Exclusion Criteria:

* Personnel not providing or supervising direct services (e.g., administrative staff) are not included as most of the measures will not be applicable to these staff.
* Participants must be at least 18 years of age and employed at one of the participating agencies.
B: 1. Working in the ward more than 2 months
2. To work at university hospital depend to Tehran University of Medical Sciences
3. Asking and be assuring about continuing their job at least for next three month
4. Asking their age, gender, work experience

Exclusion criteria

1. do not want to cooperate in this project
2. some nurses who intend to move to another places after 2 month
3. nurses who were not ready to filling out the the questionnaires due to their movement to another ward
C: Inclusion criteria (on-site cardiac arrest team):

* Are 18 years of age or older

Inclusion criteria (teleintensivist cardiac arrest team copilot):

* Are 18 years of age or older
* Are a board-certified or board-eligible critical care physician
* Provide clinical care through the Intermountain Healthcare Telecritical Care program

Exclusion criteria (both groups):

* Are under 18 years of age
* Are a member of the study research team
D: Inclusion Criteria:

* 18 year old adult
* member of Mayo care team in the Midwest

Exclusion Criteria:

-Unable to provide consent

Answer: A
Please select the eligibility criteria that correspond to the clinical trial below.
Title: Personalization of Cover Letter and Response Rate - a Randomized Controlled Trial in the Danish Health and Morbidity Survey
Brief Summary: Several studies indicate that a survey that adapts personalized design features achieves higher participation rates. A feature can be a personalized cover letter which appears more relevant and interesting for the sample member. In the spirit of adaptive design, this study seeks to establish whether it can be advantageous for participation overall to use cover letters with targeted content and whether the effect on participation of different versions of the cover letter varies in sample subgroups in order to optimize design features in future surveys.


Options:
A: Inclusion Criteria:

* Low back pain (with or without sciatica) as the dominant musculoskeletal complaint
* 18 years or older

Exclusion Criteria:

* Spinal fractures
* Malignancy
B: Inclusion Criteria:

* individuals (including institutionalized individuals) aged 16 years or older and resident in Denmark per 1 January 2017.

Exclusion Criteria:

-
C: Inclusion Criteria:

* Adolescents/young adults aged 11-21 years
* Physician diagnosis of CKD stage 1-4
* Currently prescribed an antihypertensive medication and anticipate staying on an antihypertensive through the study duration (switching medication classes is permitted)
* Must have daily access to a Wi-Fi-enabled electronic device (e.g. iOS, Android 4.2 or higher, phone, tablet, computer) to receive private health information.

Exclusion Criteria:

* Adolescents/young adults who are on dialysis or had a kidney transplant
* Sibling participating in the study, unable to comprehend spoken English
* Cognitive delay precluding completion of study procedures
* And prescribed a liquid form of an antihypertensive medication (cannot be monitored).
D: Inclusion Criteria:

* Aged 6-24
* Own and use either an iPhone or Android smartphone
* Access to US Apple App Store or US GooglePlayStore

Exclusion Criteria:

* N/A

Answer: B
Please select the eligibility criteria that correspond to the clinical trial below.
Title: Changes in Thyroid Function Tests and Texture Following Bariatric Surgery Induced Weight Loss
Brief Summary: This study is expected to provide novel data regarding potential structural and functional changes of the thyroid gland in morbidly obese adults following significant weight loss through bariatric surgery. These data will complement evidence from epidemiological studies regarding the association of obesity and alterations in thyroid function. Potentially this study may justify further longer-term studies regarding the effects of weight gain and/or weight loss on the morphology of the thyroid gland and could help to form recommendations regarding follow-up investigations for the thyroid in morbidly obese patients.


Options:
A: Inclusion Criteria:

* Depressive disorder (PHQ-9 (\>10 score)),
* In the 3rd trimester of pregnancy,
* Aged 18 years and over,
* Intending to reside in the study area for the entire duration of the study.

Exclusion criteria:

* Mothers requiring immediate inpatient care for any reason (medical or psychiatric),
* Mothers who do not speak any of the following languages: Urdu, Punjabi, Potohari or English.
B: Inclusion Criteria:

1. Obesity (BMI \> 40 kg/m2)
2. Age: 18-65

Exclusion Criteria:

1. Diagnosis of obesity secondary to primary endocrine or systemic disease (e.g. Cushing's syndrome)
2. Evidence of clinically relevant thyroid disease
3. Chronic systematic inflammatory disease (e.g. rheumatoid arthritis)
4. Pregnancy
5. Treatment with anti-inflammatory drugs (e.g. corticosteroids)
6. Type 1 diabetes mellitus
C: Inclusion Criteria:

* Staff in one of the 36 clinics - Clinic directors, trainers, supervisors, providers of participating clinics: Community Health Workers; Nurses; and Medicine, Preventive Medicine andPsychiatric Technicians.

Exclusion Criteria:

* Other clinic staff besides clinic directors, trainers, supervisors, providers of participating clinics: Community Health Workers; Nurses; and Medicine, Preventive Medicine andPsychiatric Technicians.
D: Inclusion Criteria:

* Age 18 or above
* Able to speak and understand Arabic
* Syrian under temporary protection status
* Presence of psychological distress, as shown by a score of 3 or more at the 12 item General Health Questionnaire (GHQ-12 ≥ 3)

Exclusion Criteria:

* Presence of any mental disorders according to DSM-V and ICD-10, as shown by a positive M.I.N.I.
* Acute medical conditions contraindicating study participation, based on clinical judgment of the health care professional with a clinical background who performs the screening
* Clinical evidence of imminent suicide risk or suicide risk scored as "moderate or high" (or a positive suicidality behaviour disorder) by the M.I.N.I. (section SUICIDALITY)
* Clinical evidence that the decision-making capacity is impaired

Answer: B
Please select the eligibility criteria that correspond to the clinical trial below.
Title: Financial Incentives to Increase Pediatric HIV Testing
Brief Summary: The purpose of this study is to determine whether giving small financial incentives will motivate parents to test their children for HIV.


Options:
A: Inclusion Criteria:

* Living in the catchment area of a health center under the study

Exclusion Criteria:

* Mother or tutor of the child not available for the survey
* Head of household or husband of the mother of the child not available for the survey
B: Inclusion Criteria:

* Parent/caregiver receiving HIV care
* Parent/caregiver has one or more children \<13 years old
* Child is HIV exposed (parent/caregiver report or clinic confirmation)
* Caregiver reports child's HIV status is unknown

Exclusion Criteria:

* None

  * The investigators reserve the right to exclude any potential enrollee who is deemed to be at high personal risk, or whose children are at high personal risk, of interpersonal violence, by study participation .
C: Inclusion Criteria:

* Hospitalization due to malaria
* Non per os

Exclusion Criteria:

* Consent from parent/caretaker declined
D: Inclusion Criteria:

* Health facility (level 3) in Western or Rift valley province, within the Academic Model Providing Access to Healthcare (AMPATH) catchment area
* Consent from Provincial Medical Officer of Health, District Medical Officer of Health and Health facility in-charge
* Functioning laboratory including microscopic diagnosis of malaria and at least one laboratory technician.

Exclusion Criteria:

* Lack of consent from any level
* Lack of adequate laboratory infrastructure or personnel

Answer: B
Please select the eligibility criteria that correspond to the clinical trial below.
Title: Immune Benefits of Consumption of Dairy Yogurt Containing Functional Probiotics Among Individuals Over 60 Years Old
Brief Summary: To investigate the impact of consuming dairy yogurt on immun function including natural killer (NK) cell activity, circulating levels of cytokines, and immunoglobulin (Ig) in elderly.


Options:
A: Inclusion Criteria:

* Healthy children attending day care at kindergartens located in the Zagreb's city centre
* Age from 1 year to 7 years
* Attendance at daycare centers: \> 3 days per week
* Signed informed consent by the parents

Exclusion Criteria:

* Immunodeficiency
* Receiving probiotic and /or prebiotic products prior to enrolment (2 weeks prior to study start)
* Neoplasms
* Severe chronic disorders
B: Inclusion Criteria:

* Child 36-48 months of age
* Child is currently attending a daycare and has attended for 6 months or less
* Has consumed cow's milk or a cow's milk-based beverage during the 48 hours prior to randomization
* Signed informed consent

Exclusion Criteria:

* Child who received any food product or supplement containing probiotics or prebiotics in the 15 days prior to randomization
* Child with allergy to gluten or serious concurrent illness that will interfere in the general management of the child
* Child with diarrhea or acute respiratory infection during the 48 hours prior to randomization
* Child's z-score of weight for height \< -3 according to World Health Organization criteria
C: Inclusion Criteria:

* Able to give informed consent
* Over 60 years old without any health problems
* The levels of white blood cells within range 4x10\^3/μL\~10x10\^3/μL

Exclusion Criteria:

* Individuals who get a cold
* Diabetes
* Hypersensitivity or disease history for milk protein
* Epilepsy, neurological, or psychological disease
* Alcoholism or drug addiction
* Liver disease or severe kidney failure disease
* Inflammation-related disease
* Consumption of other test products or drugs within 1 month prior to screening
* Regular consumption of immune-related functional foods including yogurt or milk within 1 month prior to screening
* History of inflammation-related disease or taking medication to treat inflammation-related disease within 1 month prior to screening
* History of cancer within 5 years
* Any inappropriate condition
D: Inclusion Criteria:

* Healthy 1 month infants exclusively formula-fed

Exclusion Criteria:

* gastrointestinal disorders (history of chronic diarrhoea or constipation, gastroesophageal reflux)
* gastrointestinal surgery
* cow's milk protein allergy
* metabolic disorders (diabetes, lactose intolerance)
* immune deficiency
* antibiotic prescription 1-week prior to inclusion and previous use of formula containing prebiotics or probiotics

Answer: C
Please select the eligibility criteria that correspond to the clinical trial below.
Title: Prospective, Randomized Study of Long-term Hemodialysis Catheter Removal, Versus Guidewire Exchange to Treat Catheter Related Blood Stream Infection
Brief Summary: Prospective, randomized Study of tunneled cuffed hemodialysis catheter removal and delayed replacement, versus exchange over a guidewire to treat catheter related blood stream infection


Options:
A: Inclusion Criteria:

* All patients end stage renal disease on hemodialysis from tunneled cuffed dialysis catheters with suspected catheter-related bloodstream infection with no identifiable infection source except the catheter were included.

Exclusion Criteria:

* metastatic infection,
B: Inclusion Criteria:

* Any adult (≥ 18 years of age) who has ESRD and a prevalent or incident tunneled hemodialysis catheter with bacteremia will be eligible for enrollment.

Exclusion Criteria:

* The following patients will be excluded: 1) patient is unable (and no guardian or legal representative is available) or unwilling to provide informed consent, 2) patient is allergic to NAC, tigecycline, minocycline, or heparin, 3) patient has evidence of a complicated bacteremia such as endocarditis, septic thrombophlebitis, septic emboli, osteomyelitis, deep seated abscess, or hypotension requiring use of vasopressors, 4) patient has evidence of an exit site infection around the catheter such as a pus pocket, purulent drainage, or erythema, 5) patient is pregnant or will become pregnant, 6) the infection is due to an organism that is resistant to tigecycline such as Candida or Pseudomonas species.
C: Inclusion Criteria:

* Patients of both genders, over 18 years,
* Patients admitted in ICU
* Dialysis catheter insertion for renal replacement therapy
* At least two renal replacement therapy sessions
* Written informed consent
* Social security

Exclusion Criteria:

* Pregnant or breastfeeding women
* Patient requiring dialysis on arteriovenous fistula or permanent catheter
* Known allergy to ethanol
* Dialysis catheter covered or impregnated with antimicrobial agent
* Dialysis catheter insertion before ICU admission
* Single-lumen dialysis catheters
* Patient whose death is likely to occur within hours after admission to ICU
D: Inclusion Criteria:

* All patients dialyzing with a central venous catheter

Exclusion Criteria:

* Known allergy to chlorhexidine

Answer: A
Please select the eligibility criteria that correspond to the clinical trial below.
Title: Team-Based Delivery of Care in Outpatient Settings: An Experimental Investigation
Brief Summary: Through this research we intend to evaluate whether a team-based care delivery approach using daily huddles is effective in improving caregiver and patient outcomes in primary care setting. This approach is expected to not only lead to effective primary care delivery outcomes, but also result in greater team morale, reduced burnout, and a higher rate of innovation.


Options:
A: Inclusion Criteria:

* 18 year old adult
* member of Mayo care team in the Midwest

Exclusion Criteria:

-Unable to provide consent
B: Inclusion Criteria:

* Substance use disorder treatment service providers, supervisors, agency executives/managers
* Supervisors will be the only individuals eligible to participate in the experimental (LOCI) or control condition (internet based) leadership intervention.
* Only supervisors in the experimental (LOCI) condition will be eligible to participate in focus groups.
* Only agency executives/managers participating in the organizational strategy development meetings of the LOCI intervention condition will be eligible to participate in interviews.

Exclusion Criteria:

* Personnel not providing or supervising direct services (e.g., administrative staff) are not included as most of the measures will not be applicable to these staff.
* Participants must be at least 18 years of age and employed at one of the participating agencies.
C: Inclusion Criteria:

* All staff nominated by the respective districts that have been selected, but not deployed yet, for integrated health system leadership, management and governance for intervention by Amhara regional health office in the study setting have been included.

Exclusion Criteria:

* No exclusion criteria
D: Inclusion Criteria: Postgraduate trainees in PGY 3 or higher -

Exclusion Criteria: Program director does not allow participation

-

Answer: A
Please select the eligibility criteria that correspond to the clinical trial below.
Title: Amonocenter, Prospective, Randomized Clinical Trial to Investigate the Removal Time of Urinary Catheter After Laparoscopic Anterior Resection of the Rectum.
Brief Summary: Traditionally these catheters are retained for 7 days, because a higher incidence of urinary retention is related to early removal of the urinary catheter. However, recently Enhanced Recovery After Surgery presents that urinary catheters placed via the urethra can be withdrawn 48 hours after colon/rectal surgery in patients receiving epidural pain relief，but there is no clear data on the incidence of urine retention.Longer retaining time of urethral catheter would induce the urinary tract infection while early removal of urethral catheter is considered to develop acute retention of urine due to lack of sensation when the bladder is full. Taking the comfort and mobility for faster rehabilitation of patients into account, the investigators aim at obtain the optimal removal time of urinary catheter after after laparoscopic anterior resection of the rectum


Options:
A: Inclusion Criteria:

* patients receiving Piver III radical hysterectomy
* catheterization over 7 days

Exclusion Criteria:

* catheterization shorter than 7 days
B: Inclusion Criteria:

* Women undergoing minimally invasive sacrocolpopexy
* Sacrocolpopexy with or without concomitant procedures
* Patients having the first start surgery of the day to standardize hospital time.

Exclusion Criteria:

* Elevated post void residual (PVR)
* Mobility problems
* Neurological conditions
* Intra-operative cystotomy or urinary tract injury
C: Inclusion Criteria:

* Uterine fibroids
* Endometriosis
* Abnormal bleeding
* Uterine prolapse and intra-epithelial neoplasia of the cervix grade 3

Exclusion Criteria:

* If they experienced pelvic reconstructive surgery for pelvic organ prolapse or stress urinary incontinence
* If they have bacteriuria and clinical urinary tract symptoms, e.g. dysuria, frequency, urgency and stress incontinence before surgery
D: Inclusion Criteria:

1. Competent to consent to participate in trial
2. Patients with rectal cancer who underwent total or tumor-specific-mesorectal excision with colorectal or colonanal anastomosis
3. Elective surgery
4. ASA classification of 1\~3
5. If male, international prostate symptom score \<20.

Exclusion Criteria:

1. Combined pelvic surgery(pelvic lymph node dissection, hysterectomy, salpingo-oophorectomy, posterior vaginectomy, cystectomy, ureteral double-J stenting, ureterectomy, ureteroureterostomy, prostatectomy)
2. Postoperative complications with a Dindo grade III or more
3. Known urinary disease(end-stage renal disease, benign prostatic hyperplasia, neurogenic bladder, malignancy)

Answer: D
Please select the eligibility criteria that correspond to the clinical trial below.
Title: The Impact of Trimodal Prehabilitation Strategy on Perioperative Functional Capability and Prognosis of Patients Undergoing Thoracoscopic Lobectomy for Lung Cancer：a Randomized Controlled Trail
Brief Summary: The process of enhancing an individual's functional capacity to optimize physiologic reserves before an operation to withstand the stress of surgery has been coined prehabilitation. This is a prospective randomized controlled trail, designed to explore if the patients who take thoracoscopic lobectomy for lung cancer will benefit from family trimodal prehabilitation strategy. Trimodal prehabilitation includes exercise, nutrition supplement and physiology management preoperatively. It starts from the day that patients decide to take the surgery until the day before surgery, lasting 2\~3 week in our hospital. And we follow-up patients until 8 weeks after surgery to investigate if trimodal prehabilitation strategy can improve the postoperative functional recovery，reduce complications and improve prognosis.


Options:
A: Inclusion Criteria:

* referred for scheduled surgery for nonmetastasized colorectal cancer
* age \> 18 years old

Exclusion Criteria:

* asa 4-5
* Poor English or French comprehension
* severe co-morbid disease interfering with ability to perform exercise at home or complete testing
B: Inclusion Criteria:

* 18 and older
* referred electively for resection of malignant esophageal lesion

Exclusion Criteria:

* American Society of Anesthesiologists (ASA) health status class 4-5
* Dementia and psychosis
* Disabling orthopedic and neuromuscular disease
* Severe cardiac abnormalities
* Severe end-organ disease such as cardiac failure (New York Heart Association classes I-IV)
* COPD
* renal failure (creatinine \> 1.5 mg/dl, and hepatic failure ALT and AST \>50% over the normal range)
* Morbid obesity (BMI \>30)
* Anemia (hematocrit \< 30 %, haemoglobin \<10g/dl, albumin \< 25mg/dl)
C: Inclusion Criteria:

* Colorectal cancer patient undergoing resection
* Frail or intermediately frail patients (Fried score 2 and above)

Exclusion Criteria:

* Unable to communicate in French or English
* Premorbid conditions contraindicating physical exercise (dementia, Parkinson Disease, previous stroke with paresis, taking carbidopa/levodopa, donepezil or antidepressants)
D: Inclusion Criteria:

1. Outpatient of thoracic surgery department in Peking Union Medical College Hospital
2. From 18 y/o to 70 y/o
3. Suspected of lung cancer
4. Decide to take the elective thoracoscopic surgery in Peking Union Medical College Hospital

Exclusion Criteria:

1. Refuse or fail to cooperate the study (due to any reason)
2. ASA grade ≥ III
3. Unable to tolerate prehabilitaion strategy (including exercise guide, whey protein and psycho-relaxation exercise)
4. Other severe cardio-pulmonary diseases that would affect the 6MWD

Answer: D